nitrites has been researched along with valsartan in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Cheng, ZJ; Fiebeler, A; Ganten, D; Ganten, U; Lapatto, R; Luft, FC; Mervaala, EM; Müller, DN; Nurminen, K; Tikkanen, I; Vapaatalo, H | 1 |
Abadir, PM; Carey, RM; Siragy, HM | 1 |
Daneshtalab, N; Jamali, F; Lewanczuk, RZ; Russell, A | 1 |
Imanishi, M; Kitabayashi, C; Konishi, Y; Maeda, I; Masada, M; Morikawa, T; Nishiyama, A; Okada, N; Shirahashi, N; Wilcox, CS | 1 |
Gao, J; Goodchild, TT; Kapusta, DR; Lefer, DJ; Li, Z; Polhemus, DJ; Scarborough, AL; Smart, FW; Trivedi, RK; Varner, KJ; Xia, H | 1 |
Hu, T; Liu, X | 1 |
Jaggi, AS; Kaur, S; Kumar, K; Singh, N | 1 |
2 trial(s) available for nitrites and valsartan
Article | Year |
---|---|
Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.
Topics: Administration, Oral; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Area Under Curve; Arthritis, Rheumatoid; Blood Pressure; Chromatography, High Pressure Liquid; Down-Regulation; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nitrites; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Valine; Valsartan | 2004 |
Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin Receptor Antagonists; Biopterins; Blood Pressure; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Hemodynamics; Humans; Kidney; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Receptors, Angiotensin; Sodium Chloride, Dietary; Tetrazoles; Valine; Valsartan | 2013 |
5 other study(ies) available for nitrites and valsartan
Article | Year |
---|---|
Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes.
Topics: Acetylcholine; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Dinoprost; Disease Models, Animal; Endothelium, Vascular; F2-Isoprostanes; Humans; Hypertension; Ketone Oxidoreductases; Male; Nitrates; Nitrites; Nitroprusside; Norepinephrine; Rats; Rats, Sprague-Dawley; Renal Artery; Renin; Superoxide Dismutase; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents; Vasodilation | 2001 |
Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cyclic GMP; Extracellular Space; Imidazoles; Kidney; Mice; Mice, Knockout; Nitrates; Nitric Oxide; Nitrites; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin; Receptors, Bradykinin; Sodium; Tetrazoles; Valine; Valsartan | 2003 |
Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney.
Topics: Aminobutyrates; Angiotensin II; Animals; Biphenyl Compounds; Bisoprolol; Blood Pressure; Drug Combinations; Echocardiography; Heart Failure; Kidney; Myocardium; Neprilysin; Nitrites; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery; Renin; Reperfusion Injury; Sympathectomy; Tetrazoles; Valsartan; Ventricular Function, Left | 2017 |
Simultaneous Determination of Nitrite and Azide Ions in Valsartan.
Topics: Azides; Chromatography, Ion Exchange; Nitrites; Reproducibility of Results; Valsartan | 2021 |
Valsartan Protects in High Fat Diet During Ischemic Reperfusion Injury.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Ischemia; Cerebral Infarction; Cholesterol; Diet, High-Fat; Memory Disorders; Neuroprotective Agents; Nitrites; Rats; Rats, Wistar; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Valsartan | 2023 |